293 related articles for article (PubMed ID: 22749977)
1. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine.
Ikemura K; Inoue K; Mizutani H; Oka H; Iwamoto T; Okuda M
Eur J Pharmacol; 2012 Sep; 690(1-3):192-201. PubMed ID: 22749977
[TBL] [Abstract][Full Text] [Related]
2. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
3. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effect of trolox against ischaemia-reperfusion injury in rats.
Wongmekiat O; Thamprasert K; Lumlertgul D
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):753-9. PubMed ID: 17600552
[TBL] [Abstract][Full Text] [Related]
5. Contribution of down-regulation of intestinal and hepatic cytochrome P450 3A to increased absorption of cyclosporine A in a rat nephrosis model.
Fujita T; Yasuda S; Kamata Y; Fujita K; Ohtani Y; Kumagai Y; Majima M
J Pharmacol Exp Ther; 2008 Nov; 327(2):592-9. PubMed ID: 18725544
[TBL] [Abstract][Full Text] [Related]
6. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
[TBL] [Abstract][Full Text] [Related]
7. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
9. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.
Zhang W; Tan TM; Lim LY
Drug Metab Dispos; 2007 Jan; 35(1):110-5. PubMed ID: 17050652
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates: in vitro and in vivo evidence using cyclosporin in rats.
Hirunpanich V; Katagi J; Sethabouppha B; Sato H
Drug Metab Dispos; 2006 Feb; 34(2):305-10. PubMed ID: 16299163
[TBL] [Abstract][Full Text] [Related]
11. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats.
Dulundu E; Ozel Y; Topaloglu U; Sehirli O; Ercan F; Gedik N; Sener G
Pharmacology; 2007; 79(3):163-70. PubMed ID: 17259747
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis with mesna prevents oxidative stress induced by ischemia reperfusion in the intestine via inhibition of nuclear factor-kappaB activation.
Ypsilantis P; Tentes I; Lambropoulou M; Anagnostopoulos K; Papadopoulos N; Kortsaris A; Simopoulos C
J Gastroenterol Hepatol; 2008 Feb; 23(2):328-35. PubMed ID: 17868332
[TBL] [Abstract][Full Text] [Related]
14. Effects of peripherally and centrally applied ghrelin in the pathogenesis of ischemia-reperfusion induced injury of the small intestine.
Pawlik MW; Obuchowicz R; Biernat J; Szczepanski W; Pajdo R; KwiecieĊ S; Brzozowski T; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2011 Aug; 62(4):429-39. PubMed ID: 22100844
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.
Ikemura K; Yamamoto M; Miyazaki S; Mizutani H; Iwamoto T; Okuda M
Mol Pharmacol; 2013 Feb; 83(2):399-405. PubMed ID: 23166305
[TBL] [Abstract][Full Text] [Related]
16. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
[TBL] [Abstract][Full Text] [Related]
17. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
Matheny CJ; Ali RY; Yang X; Pollack GM
Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
[TBL] [Abstract][Full Text] [Related]
18. Effects of Trolox on the activity and gene expression of cytochrome P450 in hepatic ischemia/reperfusion.
Eum HA; Lee SM
Br J Pharmacol; 2004 May; 142(1):35-42. PubMed ID: 15051625
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein increases portal bioavailability of loperamide in mouse by reducing first-pass intestinal metabolism.
Dufek MB; Knight BM; Bridges AS; Thakker DR
Drug Metab Dispos; 2013 Mar; 41(3):642-50. PubMed ID: 23288866
[TBL] [Abstract][Full Text] [Related]
20. Effects of scutellarin on liver function after brain ischemia/reperfusion in rats.
Yang XF; He W; Lu WH; Zeng FD
Acta Pharmacol Sin; 2003 Nov; 24(11):1118-24. PubMed ID: 14627496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
